Advertisement

Picture Swiss Biotech Association MSC Swiss Biotech Days 2025 Basel 650x100px

Deals > All

Find below a list of collaborations and financings!

Total search results: 528 | Ordered by Deal: Collaboration or Financing (ascending)
1 2 3 4 5 6  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
2bind–Dynamic Biosensors: switchSENSE technology, 202209– collab technology-service with 2bind using HeliX biosensor system as certified beta customer 2022-09-01
908 Devices–ARCH Venture: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor ARCH Ventures 2019-04-29
908 Devices–Casdin Capital: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor Casdin Capital 2019-04-29
908 Devices–Manufacturing USA: grant, 201907– grant from NIIMBL for developm of at-line bioreactor process analytics tog w MilliporeSigma et al 2019-07-25
908 Devices–Northpond Ventures: investment, 201904 financing round Series E totalling $17.5m incl new + lead investor Northpond Ventures 2019-04-29
908 Devices–Razor’s Edge Ventures: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor Razor’s Edge Ventures 2019-04-29
908 Devices–Sands Capital: investment, 201904 financing round Series E totalling $17.5m incl new + co-investor Sands Capital Ventures 2019-04-29
908 Devices–Sartorius: bioprocess control technology, 202106 collab product integration Rebel media analyzer with SIMCA data exploratory tool 2021-06-22
908 Devices–Saudi Arabia: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor Saudi Aramco Energy Ventures 2019-04-29
908 Devices–Schlumberger: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor Schlumberger 2019-04-29
908 Devices–Securecell: bioprocess control technology, 202106 collab product integration Rebel media analyzer with Lucullus PIMS 2021-06-22
908 Devices–SEVERAL: investment, 201904 financing round Series E $17.5m led by new investor Northpond Ventures 2019-04-29
908 Devices–SEVERAL: investment, 202012 IPO $130m+$19.5m net $136.6m with 6.5m+975k shares common stock at $20/share at Nasdaq Global Market 2020-12-18
908 Devices–SEVERAL: investment, 202111 public offering $100.8m net $94.4m with 3.15m shares common stock at $32/share 2021-11-15
908 Devices–Tao Capital: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor Tao Capital Partners 2019-04-29
Abcam–Danaher: investment, 202308– acquisition $24/share in cash = enterprise value $5.7b incl assumed indebtedness + net of acquired cash 2023-08-28
Accenture–PerkinElmer: bioinformatics, 201904– collab product integration of PE informatics solutions into Accenture Life Sciences platform 2019-04-16
Acquifer Imaging–Bruker: investment, 202301 acquisition €na of Acquifer Imaging Gmbh + subsidiary Deltabyte GmbH by Bruker 2023-01-05
Adeptrix–Bruker: investment, 202101 financing round Series A incl new + minority investor Bruker Corp 2021-01-06
Adeptrix–SEVERAL: investment, 202101 financing round Series A closed with new + minority investor Bruker Corp 2021-01-06
Agena Bioscience–Mesa Labs: investment, 202109– acquisition $300m in cash of Agena by Mesa Laboratories ANNOUNCED 2021-09-14
Agendia–Inivata: cancer test, 202104– co-excl distribution rights €na for RaDaR liquid biopsy assay for breast cancer in North America + Europe 2021-04-28
Agilent–Akoya Biosciences: IHC diagnostics, 202301– collab developm + marketing solutions integrating Dako Omnis instrument + PhenoImager HT system
Agilent–e-MSion: mass spectrometry technology, 2019– collab co-marketing of ExD cell technology with 6500 Series LC-/Q-TOF 2023-03-09
Agilent–Exact Sciences: investment, 202309– acquisition €na of Resolution Bioscience by Exact Sciences from Agilent 2023-09-12
Agilent–Frost & Sullivan: market research, 201906 supply service survey of pharma lab leaders on lab workflows by F&S 2019-06-04
Agilent–Hamamatsu: digital pathology, 202303– collab distribution of NanoZoomer digital pathology slide scanners by Agilent 2023-03-10
Agilent–Mettler-Toledo: lab automation, –202206 collab developm + product integration automated + digitalised sample prep for LC/GC workflow 2022-06-01
Agilent–Mobilion: mass spectrometry, 2018– collab integration of SLIM ion mobility technology with Agilent Q-TOF MS platform 2018-01-01
Agilent–Plasmion: ionisation technology, 202301– collab co-marketing of SICRIT ion source with Agilent Ultivo LC/TQ + LC/MSD iQ MS systems 2023-01-18
Agilent–Proscia: digital pathology, 202303– collab ww distribution multi-year for Concentriq Dx platform with Agilent digital pathology solutions 2023-03-08
Agilent–Scitara: lab informatics, 202209– collab product integration of OpenLab CDS + SLIMS with Scientific Integration Platform SIP + DLX 2022-09-21
Agilent–SEVERAL: credit, 201909–202909 public offering $500m net $492.8m Senior Notes 2.75% due Sept 2029 2019-09-05
Agilent–Sigsense Technologies: lab management software, 202407 supply existent Sigsense technology available via Agilent CrossLab Connect 2024-07-29
Agilent–Visiopharm: image analysis software, 202003– collab co-marketing of Visiopharm’s AI-driven solutions for digital pathology 2020-03-02
Akribion–Bruker: investment, 202502 seed financing round totalling €8m incl co-investor Bruker Invest 2025-02-04
Akribion–High-Tech Gründerfonds: investment, 202502 seed financing round totalling €8m incl co-investor HTGF 2025-02-04
Akribion–Optimum Strategic Communications: public relations, 202502 service existent by Optimum 2025-02-04
Akribion–SEVERAL: investment, 202502 seed financing round €8m led by Carma Fund + RV Invest 2025-02-04
Aldevron–Danaher: investment, 202106– acquisition $9.6b in cash by Danaher ANNOUNCED 2021-06-17
Alphalytik Pharmaservice–Certania: investment, 202409 acquisition of Alphalytik Pharmaservice GmbH by Certania 2024-09-04
Andrew Alliance–Waters: investment, 202001 acquisition by existent investor Waters 2020-01-13
Arxspan–Bruker: investment, 201903 acquisition €na of Arxspan LLC by Bruker 2019-03-14
Aston Univ–Waters: mass spectrometer, 201911 supply first Select Series Cyclic IMS mass spectrometer installed at School of Health + Life Sciences 2019-11-07
Astrea Bioseparations–Biotage: investment, 202302– acquisition $190m in shares + $45 cash milestones of Astrea from Gamma Biosciences (KKR) 2023-02-15
Atavistik Bio–Column Group: investment, 202108 financing round Series A totalling $60m incl lead investor The Columm Group 2021-08-24
Atavistik Bio–Lux Capital: investment, 202108 financing round Series A totalling $60m incl co-investor Lux Capital 2021-08-24
Atavistik Bio–Nextech: investment, 202108 financing round Series A totalling $60m incl co-investor Nextech Invest Ltd 2021-08-24
Atavistik Bio–SEVERAL: investment, 202108 financing round Series A $60m led by The Columm Group with Lux Capital + Nextech Invest 2021-08-24
Atlas Antibodies–Genovis: MS-based analysis of biopharmaceuticals, 202208– supply service LC-MS analytics of recombinant CHO-antibodies to Evitria 2022-08-08
Atonarp–SEVERAL: investment, 201908 financing round Series C $33m 2019-08-26
Avacta–Adeptrix: MS-based SARS-CoV-2 test, 202101 collab existent developm of BAMS SARS-CoV-2 assay for research + IVD 2021-01-28
Avacta–Bruker: MS-based SARS-CoV-2 test, 202101– collab developm of BAMS SARS-CoV-2 assay on Bruker MALDI-TOF as IVD test 2021-01-28
Axel Semrau–Trajan: investment, 202111 acquisition €19.85m by Trajan Group 2021-11-18
BIA Separations–Sartorius: investment, 202010– acquisition €240m in cash + €120m in SSB shares BIA to be merged into SSB ANNOUNCED 2020-10-02
BIA Separations–Univ Zagreb: purification technology, 202002– commercial license + collab developm of virus + viral vector immunoaffinity purification 2020-02-19
Bico–RAG: investment, 202411 acquisition €26m of Nanoscribe from Bico Group by LAB14 GmbH 2024-11-21
Binding Site–Tecan: laboratory automation, 201906 collab existent developm automated solution for using MALDI-MS to diagnose blood cancers 2019-06-06
Binding Site–Thermo Fisher: investment, 202210– acquisition £2.25b in cash from shareholder group led by Nordic Capital ANNOUNCED 2022-10-31
Bio-Techne–Lunaphore: spatial omics, 202304– collab strategic partnership integrating COMET system with RNAscope technology 2023-04-17
BioAnalytix–Zukunftsfonds Heilbronn: investment, 201904 merger acquisition of BioAnalytix Inc by Protagen Protein Services GmbH 2019-04-10
BioClin Laboratories–Almac: investment, 201711 acquisition 100% of BioClin by Almac Group 2017-11-01
Biocrates–MIG Founds: investment, 201909c financing round incl MIG Fonds + GAF + Austria family office consolidation shareholder structure 2019-09-01
Biocrates–NONE: investment, 201905– bankruptcy filed for subsidiary Metanomics Health GmbH 2019-05-22
Biocrates–SEVERAL: investment, 201909c financing round incl MIG Fonds + GAF + Austria family office consolidation shareholder structure 2019-09-01
Biocrates–Xolaris Service KVG: investment, 201909c financing round incl MIG Fonds + GAF + Austria family office consolidation shareholder structure 2019-09-01
Biodesix–MRM Proteomics: MALDI-TOF mass spectrometry, 201901– collab use of iMALDI technologies to advance blood-based lung cancer test 2019-01-28
Biodesix–Oncimmune: clinical proteomic cancer test, 201906– collab excl commercialisation of EarlyCDT Lung in US by Biodesix 2019-06-28
Biogenity–Denmark (govt): investment, 202203 Innovation Fund Denmark invests in Innobooster project BioSWITCH 2022-03-23
Biognosys–Bruker: investment, 202301 acquisition €na of majority share in Biognosys by Bruker 2023-01-04
Biognosys–ETH Zürich: LiP technology, 202108 collab developm + excl license from Institute of Systems Biology 2021-08-27
Biognosys–SEVERAL: investment, 201908 financing round Series G from existing + new institutional + private investors 2019-08-08
BioLegend–PerkinElmer: investment, 202107– acquisition $5.25b in cash + shares subject to certain adjustments ANNOUNCED 2021-07-26
Biotage–KKR: investment, 202302– investment $25m tog with sale of Astrea Bioseparations by Gamma for shares resulting in 17% share in Biotage of Gamma 2023-02-15
BioTek Instruments–Agilent: investment, 201907–201908 acquisition $1.165b incl anticipated tax benefits net $1.05b 2019-07-11
Biovectra–Agilent: investment, 202407– acquisition of Biovectra for $925m by Agilent from H.I.G. Capital 2024-07-22
Blue Heron–Eurofins: investment, 201908 acquisition of Blue Heron Biotech by Eurofins Genomics LLC 2019-08-06
Boehringer–Biognosys: HRM mass spectrometry, 202007– collab using HRM/DIA MS + Spectronaut s/w for drug discovery 2020-07-23
Bohui–Aviv Analytical: mass spectrometry software, 201806– supply TAMI molecular identifcation s/w now available for expression CMS 2018-06-04
Brammer Bio–Thermo Fisher: investment, 201903– acquisition $1.7b in cash from Ampersand Capital Partners + Founders ANNOUNCED 2019-03-24
Bruker–908 Devices: sample separation technology, 201906– collab integration of ZipChip microfluidics separation with Bruker TOF systems 2019-06-03
Bruker–Adeptrix: MS-based immunoassays, 202101– collab developm BAMS assays on Bruker MALDI-MS systems 2020-01-06
Bruker–Bico: MS-based single cell proteomics, 202111– co-marketing of Cellenion’s cellenONE with timsTOF SCP mass spectrometers 2021-11-15
Bruker–Genedata: bioinformatics, 201902 collab product integration Bruker new Ready-to-Run partner 2019-02-05
Bruker–Genedata: bioinformatics, 201905– collab product integration Genedata Expressionist supports timsTOF MS systems data 2019-05-31
Bruker–Murdoch Univ: analytical technologies, 201909– collab strategic alliance with ANPC incl MS + NMR for phenomics research 2019-09-20
Bruker–Novalix: drug discovery technology, 202408– strategic collab to enable new paradigms in drug discovery 2024-08-07
Bruker–PreOmics: sample preparation technology, 201905– collab developm + marketing PreOmics iST sample preparation on timsTOF Pro MS system 2019-05-31
Bruker–Univ Nijmegen: mass spectrometry, 201904– collab establishment of joint Center of Excellence for Translational Omics at RUMC TML 2019-04-16
Bruker–Univ Utrecht: mass spectromtery, 202008– collab developm of methods using crosslinkg MS for proteomics with Heck lab 2020-08-07
BSSN Software–Merck (DE): investment, 201908 acquisition €na of BSSN Software GmbH by Merck KGaA 2019-08-06
BugLab–Aber Instruments: investment, 202009–202102 acquisition €na of assets of BugLab LLC incl IP + trademarks 2020-01-01
Bureau Veritas–Mérieux: investment, 202410– acquisition €360m of global food testing of Bureau Veritas by Mérieux NutriSciences 2024-10-07
Bureau Veritas–SGS: investment, 202501– confirmed merger discussion 2025-01-15
Cambridge Research & Instrumentation–Caliper: investment, 2010 acquisition of CRI by Caliper Life Sciences 2010-01-01
Canopy Biosciences–Ampersand: investment, 201904 strategic growth investment from Ampersand Capital Partners 2019-04-29
Canopy Biosciences–Bruker: investment, 202009 acquisition €na of Canopy Biosciences LLC by Bruker Corp 2020-09-11
CatSci–Keensight Capital: investment, 202206 investment by Keensight Capital to support expansion 2022-06-01
CatSci–Keensight Capital: investment, 202406 additional investment? by Keensight to support acquisition of Reach Separations by CatSci 2024-06-25
CatSci–Reach Separations: chromatography, 202311– collab strategic allliance offering method development for small molecule development services 2023-11-28
1 2 3 4 5 6  next pagenext page



Advertisement

Picture Swiss Biotech Association MSC Swiss Biotech Days 2025 Basel 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com


Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x300px

» top